Skip to main content

pharma social media regulation

By Jonah Comstock | 11:20 am | June 18, 2014
The FDA has, at long last, released draft guidance for how pharmaceutical companies should behave on limited-character social media platforms like Twitter and when correcting misinformation on third-party sites.